4.3. Flow Cytometry Gating Strategy

GC Giulia Catitti
MC Maria Concetta Cufaro
DB Domenico De Bellis
IC Ilaria Cicalini
SV Simone Vespa
FT Federico Tonelli
GM Giulia Miscia
LS Lorenzo Secondi
PS Pasquale Simeone
VL Vincenzo De Laurenzi
DP Damiana Pieragostino
PB Piero Del Boccio
PL Paola Lanuti
request Request a Protocol
ask Ask a question
Favorite

Figure 1A shows the gating strategy used to identify, count, and subtype circulating EVs. In detail, a forward scatter height (FSC-H)/ Side Scatter-H (SSC-H) dot-plot was used to establish a region, defined as “platelet free area”, containing the events with the EV scatter features (Figure 1A) [55,56]. Those events were represented on an LCD-H/Phalloidin-H dot-plot and EVs were identified as LCD positive/phalloidin negative dots (Figure 1B). Therefore, EVs (LCD+/Phalloidin- events) were analyzed on a CD45-H/CD41a-H dot-plot and CD45+ events were identified as leukocyte-derived EVs (Figure 1C) [18]. A CD45 negative logical gate was obtained, and the resulting population was represented on a CD31-H/CD41a-H dot-plot. Events showing the CD31+/CD41a+ phenotype were identified as platelet-derived EVs (Platelet EVs) (Figure 1D) [18], whereas the compartment was identified as endothelial-derived EVs (Figure 1D) [18]. Platelet-derived EVs (Figure 1E) and endothelial-derived EVs (Figure 1F) and all platelets (Figure 1G) were further analyzed for the activation marker CD62P. In Figure 1H, the used gating hierarchy is shown as a scheme.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A